CIK 0001528115
- Non-accelerated filer
- Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275414423
- Phone
- +1 650-822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 1,117 shares at $2.58 ($2,882)
- 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 853 shares at $2.61 ($2,226)
- 4 Open-market buy Director bought 4,115 shares at $2.46 ($10,123)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP & CHIEF SCIENTIFIC OFFICER acquired 44,963 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 44,963 shares (grant or award)
- 4 Grant or award EVP & CHIEF FINANCIAL OFFICER acquired 44,963 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP & CHIEF INNOVATION OFFICER acquired 44,963 shares (grant or award)
- 4 Grant or award EVP & CHIEF BUSINESS OFFICER acquired 44,963 shares (grant or award)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 5,521 shares at $2.96 ($16,342)
- 4 Open-market sale EVP & CHIEF SCIENTIFIC OFFICER sold 5,515 shares at $2.97 ($16,380)
- 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 8,345 shares at $2.91 ($24,284)
- 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 6,618 shares at $2.95 ($19,523)
Page 3 of 11 · 206 filings